| Completed | 3 | 445 | Canada, US | SPARK Symptom Screening Linked to Feedback to Providers | The Hospital for Sick Children, National Cancer Institute (NCI) | Pediatric Cancer, Quality of Life | 10/23 | 10/23 | | |
NCT01595048 / 2010-019224-31: Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia |
|
|
| Active, not recruiting | 2/3 | 640 | US, Canada, RoW | Rituximab, MOAB IDEC-C2B8, Prednisone, Etoposide, Lastet, Doxorubicin Hydrochloride, Cytarabine, CHX-3311, U-19920, Vincristine Sulfate, Kyocristine, Oncovin, VCR, Vincasar, Cyclophosphamide, Methotrexate, Methylprednisolone, MePRDL, Leucovorin Calcium, CF, Therapeutic Hydrocortisone, Aeroseb-HC, Cetacort, HC, Laboratory Biomarker Analysis | Children's Oncology Group, National Cancer Institute (NCI) | Childhood B Acute Lymphoblastic Leukemia, Childhood Burkitt Leukemia, Childhood Diffuse Large Cell Lymphoma, Mediastinal (Thymic) Large B-Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma | 12/20 | 12/20 | | |
NCT00904241: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma |
|
|
| Recruiting | N/A | 10000 | Europe, Canada, US, RoW | Cytology Specimen Collection Procedure, Cytologic Sampling, Laboratory Biomarker Analysis | Children's Oncology Group, National Cancer Institute (NCI) | Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma | 01/00 | | | |
| Completed | 3 | 445 | Canada, US | SPARK Symptom Screening Linked to Feedback to Providers | The Hospital for Sick Children, National Cancer Institute (NCI) | Pediatric Cancer, Quality of Life | 10/23 | 10/23 | | |
| Completed | 3 | 445 | Canada, US | SPARK Symptom Screening Linked to Feedback to Providers | The Hospital for Sick Children, National Cancer Institute (NCI) | Pediatric Cancer, Quality of Life | 10/23 | 10/23 | | |
